Cirevetmab
Product Specifications
CAS Number
2473240-98-9
Target
TGF-beta/Smad
Related Pathways
Stem Cells
Bioactivity
Cirevetmab (ZTS-00521426), a caninized monoclonal antibody targeting Canis lupus familiaris TGFB1, is classified as an immunoglobulin G2-kappa. It functions as an immunomodulator [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog